
{
"_instructions1": "This is a template for JSON files that can provide a standard way to add new services to the cloud catalog, maintained with this repository.",

"_instructions2": "Please create a new JSON file to add a new service to the catalog. While creating that file based on this template, please consider the comments below to fill the items to have a standard representation of services. Please feel free to raise an issue or give feedback for the template in the issues section (https://github.com/VHP4Safety/cloud/issues) of this repository.",


  "_ins_id": "An id for the JSON file, needs to be the same name as this JSON file.",
  "id": "ke-wp-mapping",

  "_ins_service": "// The (stylized) name of the service which will be shown as the name of the service in the catalog.",
  "service": "Molecular AOP Builder",

  "_ins_description": "A short description for the service.",
  "description": "A web application for mapping Key Events from Adverse Outcome Pathways to WikiPathways and Gene Ontology Biological Process terms, using intelligent suggestions based on gene overlap, text similarity, and BioBERT semantic embeddings.",

  "_ins_stage": "Stage / place in the workflow categories",
  "stage": "",

  "_ins_substage": "Substage for the category",
  "substage": "",

  "_ins_screenshot": "The name of the file for the service logo, needs to be the same name as the service id but with a different extension.",
  "screenshot": "ke-wp-mapping.png",

  "_ins_url": "The original URL to the service.",
  "url": "https://github.com/marvinm2/KE-WP-mapping",

  "_ins_doi": "The DOI of the document (article, preprint, etc.) related to the service.",
  "doi": "",

  "_ins_release_notes": "A url where there are release notes regarding the service.",
  "release_notes": "https://github.com/marvinm2/KE-WP-mapping/releases",

  "instance": {

    "_ins_type": "Whether the instance 'internal' or 'external'",
    "type": "internal",

    "_ins_vhp-platform": "Whether the instance running on 'development' or 'production' platform.",
    "vhp-platform": "development",

    "_ins_url": "URL to the service instance running on our servers.",
    "url": "molaop-builder.vhp4safety.nl",

    "license": "GPL-2.0",
    "version": "2.3.0",

    "ins_source": "Link to the source material of the service.",
    "source": "https://github.com/marvinm2/KE-WP-mapping",

    "_ins_docker": "Link to the repository with service's Docker container.",
    "docker": "https://github.com/marvinm2/KE-WP-mapping",

    "_ins_TRL": "Technology Readiness Level. For details, please see: https://en.wikipedia.org/wiki/Technology_readiness_level",
    "TRL": ""
  },

  "provider": {
    "contact": {
      "_ins_name": "The name of a person from the organization that provide the service.",
      "name": "Marvin Martens",
      "_ins_email": "The email of the person whose name given above.",
      "email": "marvin.martens@maastrichtuniversity.nl"
    },

    "_ins_name": "The name of the organization that provide the service.",
    "name": "Department of Translational Genomics (TGX), Maastricht University",
    "_ins_url": "An URL to the organization that provide the service.",
    "url": "https://www.maastrichtuniversity.nl/research/translational-genomics"
  },

  "_ins_access": "Information regarding the remote use of the service.",
  "access": {
    "_ins_API": "The type of API, if available.",
    "API": "REST",

    "_ins_login": "Whether the API requires authenication.",
    "login": "true",

    "packages": {
      "R": "",
      "Python": ""
    }
  },

  "_ins_intro": "Information regarding an available demo documentation available on the docs repo.",
  "intro": {
    "_ins_title": "The title of the intro on the VHP4Safety platform. Multiple entries should be separated by a ';' without any spaces between them. Note that, ideally, the number of titles should be equal to the number of urls.",
    "title": "",
    "_ins_url": "Link to the intro on the VHP4Safety platform. Multiple entries should be separated by a ';' without any spaces between them. Note that, ideally, the number of titles should be equal to the number of urls.",
    "url": ""
  },

  "demo": {
    "_ins_title": "The title of the demo?",
    "title": "",
    "_ins_url": "The link to the demo?",
    "url": ""
  },

  "workflow": {
    "_ins_title": "The title of the VHP4Safety workflow where it is being used. Multiple entries should be separated by a ';' without any spaces between them. Note that, ideally, the number of titles should be equal to the number of urls.",
    "title": "",
    "_ins_url": "Link to the workflow. Multiple entries should be separated by a ';' without any spaces between them. Note that, ideally, the number of titles should be equal to the number of urls.",
    "url": ""
  },

  "_ins_ELIXIR": "Information regarding sources available on ELIXIR.",
  "ELIXIR": {
    "_ins_biotools": "The keyword for the link to the source on bio.tools.",
    "biotools": "",

    "_ins_tess": "The keyword for a search link to the source on ELIXIR TeSS (https://tess.elixir-europe.org/).",
    "tess": "",

    "_ins_fairsharing": "The DOI for the entry on FAIRsharing.org",
    "fairsharing": ""
  },

  "Other": {
    "_ins_wikipedia": "Wikipedia page",
    "wikipedia": "",
    "_ins_rsd": "Dutch Research Software Directory.",
    "rsd": ""
  },


  "_ins_NAM-validation": "Information about NAM validation stage as described in the 2017 RIVM report (https://www.rivm.nl/documenten/landschap-3v-methoden-risicobeoordeling-chemische-stoffen), Answer whether the service has completed the stage using as 'yes' or 'no'.",
  "NAM-validation": {
    "_ins_NAM-stage1": "Stage 1: Research & development.",
    "NAM-stage-1": "",

    "_ins_NAM-stage2": "Stage 2: Validation.",
    "NAM-stage-2": "",

    "_ins_NAM-stage3": "Stage 3: Evaluation.",
    "NAM-stage-3": "",

    "_ins_NAM-stage4": "Stage 4: Acceptation.",
    "NAM-stage-4": "",

    "_ins_NAM-stage5": "Stage 5: Implementation.",
    "NAM-stage-5": ""
  },

  "_ins_VHP-persona": "Whether the service is used by one or more of the VHP persona's. Answer as 'true' or 'false' (e.g., persona-1: 'true' to attribute a service to a persona).",
  "VHP-persona": {
    "persona-1": "",
    "persona-2": "",
    "persona-3": ""
  },

  "_ins_regulatory-question": "Whether the service is relevant to any of the regulatory questions (https://docs.vhp4safety.nl/en/latest/introduction/case_studies_and_regulatory_questions.html). Answer either 'true' or 'false'",
  "regulatory-question": {
    "_cs_1": "Kidney case study",

    "_ins_1a": "1a: What is a safe dose for cisplatin/tacrolimus in patients with respect to chronic kidney disease?",
    "1a": "",

    "_ins_1b": "1b: How can we take into account variability in activity/expression of P-gp in patients that underwent a transplantation?",
    "1b": "",

    "_cs_2": "Parkinson case study",

    "_ins_2a": "2a: Can compound X cause Parkinson's Disease?",
    "2a": "",

    "_ins_2b": "2b: Can we identify groups at extra risk to develop Parkinson's Disease after exposure to compound X?",
    "2b": "",

    "_cs_3": "Thyroid Hormone Case Study",

    "_ins_3a": "3a: What information about a substance do we need to give an advice to women in their early pregnancy to decide whether the substance can be used?",
    "3a": "",

    "_ins_3b": "3b: Does compound X influence the thyroid-mediated brain development in the fetus resulting in cognitive impairment in children?",
    "3b": ""
  }
}
